Nasdaq · CIK 0001660334
VRCA Verrica Pharmaceuticals Inc.
Insider trading from SEC Form 4. Last filing Dec 30, 2025. Close $4.11 on Oct 9, 2026, +25% from the 52-week low and -55% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Price and insider trades, last year
VRCAOct 9, 2026 · close 4.11
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Verrica Pharmaceuticals Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | John J. Kirby Interim CFO buy | $15k 3,536 shares | +65% | +56% from low-60% from high | |
| 73Notable | Paul B Manning director, owner buy | $18M 4,126,142 shares | +160% | +56% from low-60% from high | |
| 74Notable | Jayson Rieger CEO and President buy | $400k 94,311 shares | +107% | +56% from low-60% from high | |
| 46Moderate | Noah L. Rosenberg CMO buy | $10,000 2,357 shares | - | +56% from low-60% from high | |
| 59Moderate | David Zawitz Chief Operating Officer buy | $42k 10,000 shares | +91% | +56% from low-60% from high | |
| 15Weak | Christopher G. Hayes CHIEF LEGAL OFFICER sell | $2,805 4,315 shares | -2% | - |
Transactions
The last 39 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | John J. Kirby Interim CFO | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 18,962 | Dec 30, 2025 |
| Nov 25, 2025 | John J. Kirby Interim CFO | POpen-market purchase Common Stock | +3,536 | $4.24 | $15k | 8,962 | Nov 25, 2025 |
| Nov 25, 2025 | David Zawitz Chief Operating Officer | POpen-market purchase Common Stock | +10,000 | $4.24 | $42k | 21,000 | Nov 25, 2025 |
| Nov 25, 2025 | Noah L. Rosenberg CMO | POpen-market purchase Common Stock | +2,357 | $4.24 | $10,000 | 2,357 | Nov 25, 2025 |
| Nov 25, 2025 | Jayson Rieger CEO and President | POpen-market purchase Common Stock | +94,311 | $4.24 | $400k | 182,593 | Nov 25, 2025 |
| Nov 25, 2025 | Paul B Manning director, owner | POpen-market purchase Common Stock | +1,375,380 | $4.24 | $5.8M | 3,958,189 | Nov 25, 2025 |
| Nov 25, 2025 | Paul B Manning director, owner | POpen-market purchase Common Stockindirect: See footnote | +2,750,762 | $4.24 | $12M | 3,348,372 | Nov 25, 2025 |
| Nov 25, 2025 | Noah L. Rosenberg CMO | POpen-market purchase Series C Warrant (right to buy)derivative | +589 | - | - | 589 | Nov 25, 2025 |
| Nov 25, 2025 | John J. Kirby Interim CFO | POpen-market purchase Series C Warrant (right to buy)derivative | +884 | - | - | 884 | Nov 25, 2025 |
| Nov 25, 2025 | David Zawitz Chief Operating Officer | POpen-market purchase Series C Warrant (right to buy)derivative | +2,500 | - | - | 2,500 | Nov 25, 2025 |
| Nov 25, 2025 | Jayson Rieger CEO and President | POpen-market purchase Series C Warrant (right to buy)derivative | +23,577 | - | - | 23,577 | Nov 25, 2025 |
| Nov 25, 2025 | Paul B Manning director, owner | POpen-market purchase Series C Warrant (right to buy)derivative | +343,845 | - | - | 343,845 | Nov 25, 2025 |
| Nov 25, 2025 | Paul B Manning director, owner | POpen-market purchase Series C Warrant (right to buy)derivativeindirect: See footnote | +687,690 | - | - | 687,690 | Nov 25, 2025 |
| Jun 5, 2025 | Gavin Corcoran director | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 9, 2025 |
| Jun 5, 2025 | Lawrence Eichenfield director | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 9, 2025 |
| Jun 5, 2025 | Diem Nguyen director | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 9, 2025 |
| Jun 5, 2025 | Mark A Prygocki Sr director | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 9, 2025 |
| Mar 31, 2025 | Gavin Corcoran director | AGrant or award Stock Option (right to buy)derivative | +17,502 | $0.00 | $0 | 17,502 | Apr 2, 2025 |
| Mar 17, 2025 | Christopher G. Hayes CHIEF LEGAL OFFICER | SOpen-market sale Common Stock | -4,315 | $0.65 | $2,805 | 176,458 | Mar 18, 2025 |
| Mar 14, 2025 | Christopher G. Hayes CHIEF LEGAL OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +250,000 | $0.00 | $0 | 250,000 | Mar 18, 2025 |
| Dec 9, 2024 | David Zawitz Chief Operating Officer | AGrant or award Employee Stock Option (right to buy)derivative | +950,000 | $0.00 | $0 | 950,000 | Dec 9, 2024 |
| Nov 22, 2024 | Paul B Manning director, owner | POpen-market purchase Common Stock | +18,426,966 | - | - | 26,278,094 | Nov 26, 2024 |
| Nov 22, 2024 | Jayson Rieger CEO and President | POpen-market purchase Common Stock | +280,898 | - | - | 832,826 | Nov 26, 2024 |
| Nov 22, 2024 | John A Stalfort III director | POpen-market purchase Common Stock | +1,123,595 | - | - | 1,823,800 | Nov 26, 2024 |
| Nov 26, 2024 | Jayson Rieger CEO and President | GGift Common Stock | +50,000 | $0.00 | $0 | 882,826 | Nov 26, 2024 |
| Nov 26, 2024 | John A Stalfort III director | GGift Common Stock | +50,000 | $0.00 | $0 | 1,873,800 | Nov 26, 2024 |
| Nov 22, 2024 | Paul B Manning director, owner | POpen-market purchase Common Stockindirect: See footnote | +4,494,382 | - | - | 5,976,101 | Nov 26, 2024 |
| Nov 26, 2024 | Paul B Manning director, owner | GGift Common Stock | -450,000 | $0.00 | $0 | 25,828,094 | Nov 26, 2024 |
| Nov 22, 2024 | John A Stalfort III director | POpen-market purchase Series A Warrants (right to buy)derivative | +561,797 | - | - | 561,797 | Nov 26, 2024 |
| Nov 22, 2024 | John A Stalfort III director | POpen-market purchase Series B Warrants (right to buy)derivative | +561,797 | - | - | 561,797 | Nov 26, 2024 |
| Nov 22, 2024 | Jayson Rieger CEO and President | POpen-market purchase Series A Warrants (right to buy)derivative | +140,449 | - | - | 140,449 | Nov 26, 2024 |
| Nov 22, 2024 | Jayson Rieger CEO and President | POpen-market purchase Series B Warrants (right to buy)derivative | +140,449 | - | - | 140,449 | Nov 26, 2024 |
| Nov 22, 2024 | Paul B Manning director, owner | POpen-market purchase Series A Warrants (right to buy)derivative | +9,213,483 | - | - | 9,213,483 | Nov 26, 2024 |
| Nov 22, 2024 | Paul B Manning director, owner | POpen-market purchase Series B Warrants (right to buy)derivative | +9,213,483 | - | - | 9,213,483 | Nov 26, 2024 |
| Nov 22, 2024 | Paul B Manning director, owner | POpen-market purchase Series A Warrants (right to buy)derivativeindirect: See footnote | +2,247,191 | - | - | 2,247,191 | Nov 26, 2024 |
| Nov 22, 2024 | Paul B Manning director, owner | POpen-market purchase Series B Warrants (right to buy)derivativeindirect: See footnote | +2,247,191 | - | - | 2,247,191 | Nov 26, 2024 |
| Nov 6, 2024 | John J. Kirby Interim CFO | AGrant or award Common Stock | +54,267 | $0.00 | $0 | 54,267 | Nov 6, 2024 |
| Nov 6, 2024 | Jayson Rieger CEO and President | AGrant or award Employee Stock Option (right to buy)derivative | +2,000,000 | $0.00 | $0 | 2,000,000 | Nov 6, 2024 |
| Oct 9, 2024 | Christopher G. Hayes CHIEF LEGAL OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Oct 11, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Gavin Corcorandirector
- Lawrence Eichenfielddirector
- Christopher G. HayesCHIEF LEGAL OFFICER
- John J. KirbyInterim CFO
- Paul B Manningdirector, owner
- Diem Nguyenceo, officer, director
- Mark A Prygocki Srdirector
- Jayson RiegerCEO and President
- Noah L. RosenbergCMO
- John A Stalfort IIIdirector
- David ZawitzChief Operating Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.